GÜLSEREN YÜCESOY, MELTEM ÖZDEN, İZZET YÜCESOY, JALE DAL, HALE MARAL, MUSTAFA GÖKTAN
Gynecology Obstetrics & Reproductive Medicine - 2004;10(1):10-12
OBJECTIVE: To investigate the role of maternal plasma fibronectin levels in predicting preterm delivery. STUDY DESIGN: The study involved 90 singleton primigravid pregnancy cases. Maternal venous blood samples were collected from all patients at 28 gestational weeks. The participants were observed at two-weeks intervals until term. Those who developed the pregnancy complications such as preeclampsia, intrauterine growth retardation, gestational diabetes mellitus during the course of pregnancy and those who did not attend the follow- up clinics were excluded from the study. The fibronectin values of preterm deliveries were compared with those of term deliveries. RESULTS: Of the total 90 cases, 80 completed the study. The maternal plasma fibronectin levels of the preterm and term delivery cases were 445 (133-650) and 395 (55-650) mg/L respectively. There was no statistical significant difference between the two groups. CONCLUSION: It was concluded that maternal plasma fibronectin level was not an early predictor for preterm labor or preterm delivery.
